HIGHLIGHTS
- who: Angela Damato et al. from the (UNIVERSITY) have published the article: New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer, in the Journal: Life 2022, 12, 1137. of /2022/
- what: In this study, 22 CRC patients were treated with PD1/PD-L1 inhibitors, and the response was assessed using RECIST 1.1 Criteria. This study demonstrated a prognostic value of higher expression of TIM-3, PDL1- LAG3, and PD1 at the tumor associated with poor survival, while high expression at the stroma correlated with improvement of 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.